Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.08M Sell
10,800
-1,800
-14% -$926K ﹤0.01% 2616
2026
Q2
$10.1M Buy
12,600
+6,400
+103% +$4.26M ﹤0.01% 1804
2026
Q1
$3.38M Buy
6,200
+2,100
+51% +$856K ﹤0.01% 2484
2025
Q4
$1.28M Hold
4,100
– – ﹤0.01% 3375
2025
Q3
$1.11M Sell
4,100
-1,200
-23% -$275K ﹤0.01% 3396
2025
Q2
$1.17M Buy
5,300
+3,500
+194% +$631K ﹤0.01% 3123
2025
Q1
$236K Buy
+1,800
New +$251K ﹤0.01% 3861

Other funds holding AGX

David Shaw's AGX Position: Q3 2026 in Review

David Shaw increased its Argan (AGX) stake by 195% in Q3 2026, buying an estimated $3.72M and bringing the position to 10,942 shares worth $4.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

David Shaw first reported a position in AGX in Q2 2014 and has held it in 20 quarters since. The position peaked at $6.81M in Q1 2026. 492 funds tracked by Wall St. Rank hold AGX as of Q3 2026.

  • David Shaw held 10,942 shares of Argan worth $4.14M as of Q3 2026.
  • David Shaw bought 7,232 Argan shares in Q3 2026, an estimated $3.72M.
  • Argan made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #2600 holding.
  • David Shaw first reported a position in Argan in Q2 2014 and has held it in 20 quarters since.
  • David Shaw's Argan position peaked at $6.81M in Q1 2026.
  • 492 funds tracked by Wall St. Rank held Argan as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.